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Turnaround timeWhole genome sequencing (WGS) is increasingly employed in clinical settings, though few assessments of
turnaround times (TAT) have been performed in real-time. In this study, WGS was used to investigate an
unfolding outbreak of vancomycin resistant Enterococcus faecium (VRE) among 3 patients in the ICU of a tertiary
care hospital. Including overnight culturing, a TAT of just 48.5 h for a comprehensive report was achievable using
an Illumina Miseq benchtop sequencer. WGS revealed that isolates from patient 2 and 3 differed from that of
patient 1 by a single nucleotide polymorphism (SNP), indicating nosocomial transmission. However, the
unparalleled resolution provided byWGS suggested that nosocomial transmission involved two separate events
from patient 1 to patient 2 and 3, and not a linear transmission suspected by the time line. Rapid TAT’s are
achievable using WGS in the clinical setting and can provide an unprecedented level of resolution for
outbreak investigations.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Over the past decade, the advent of next generation sequencing
technology (NGS) has revolutionized the ﬁeld of whole genome
sequencing (WGS) and molecular biology (Mardis, 2011). It has been
incorporated into diverse disciplines (Ankala and Hegde, 2014; van
Dijk et al., 2014), and lower costs combined with higher throughput
and accuracy has greatly expanded its accessibility tomany laboratories
(Goldberg et al., 2015).WGS is particularly suited to clinicalmicrobiology,
where relatively small genomes allow multiple isolates to be sequenced
simultaneously, and with high coverage (Didelot et al., 2012; Pak and
Kasarskis, 2015). Indeed, it has been speculated that WGS could be “the
most signiﬁcant advance in diagnostic microbiology and surveillance
since the advent of in vitro culture” (Koser et al., 2012a).
Despite the obvious advantages of WGS for clinical microbiology,
adoption has been slow (Goldberg et al., 2015). This can be attributed
to outstanding challenges in both the “wet” (i.e. sample preparation,
library construction, and sequencing) and “dry” (i.e. bioinformatic
support) aspects of NGS (Aziz et al., 2015), including the lack ofann.patrick@gmail.com
ss article under the CC BY-NC-ND licestandards and reference materials (Gargis et al., 2012), the need for
greater automation (Gargis et al., 2012), and inadequate bioinformatics
infrastructure (Fricke and Rasko, 2014).
While some applications, such as single cell microbiology and clini-
cal metagenomics, are currently conﬁned to translational research
(Pallen et al., 2010), WGS is increasingly being employed for outbreak
investigation and bacterial genomic epidemiology, species identiﬁca-
tion, and to a lesser extent, culture independent microbiology and sus-
ceptibility testing (Koser et al., 2012a). In particular, WGS has been
instrumental in tracking outbreaks and unravelling the epidemiology
of carbapenem-resistant Klebsiella pneumoniae (Lopez-Camacho et al.,
2014; Snitkin et al., 2012), methicillin-resistant Staphylococcus aureus
(MRSA) (Eyre et al., 2012; Harris et al., 2010, 2013; Harrison et al.,
2013; Koser et al., 2012b), Clostridium difﬁcile (Eyre et al., 2012; He
et al., 2013), enterohemorrhagic Escherichia coli (Rasko et al., 2011;
Underwood et al., 2013), and Chlamydia trachomatis (Harris et al.,
2012). These studies have been invaluable in expanding our knowledge
of bacterial epidemiology, and provide striking examples of the trans-
formative potential of WGS.
Current typing methods lack comprehensive resolution and can be
time-consuming and expensive (Fournier et al., 2007). WGS has the
potential to revolutionize this paradigm by providing the ultimate
level of resolution. A critical component of these investigations isnse (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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WGS can meet this challenge. Previous studies have shown that short
TAT (48–96 h) can be achieved using WGS (Eyre et al., 2012; Harris
et al., 2013; Koser et al., 2012b), but the majority of these TAT’s have
been artiﬁcial and not conducted in real-time. In this study, we demon-
strate that WGS can readily provide accurate and comprehensive feed-
back on potential outbreaks in just 2 days, allowing real-time feedback
to the requesting facility and resulting in an appropriate and compre-
hensive response by Infection Control (IC) departments.2. Methods
2.1. Bacterial isolates
Three vancomycin-resistant Enterococcus faecium (VRE)with identi-
cal antibiotic susceptibilitieswere isolated from3 patients housed at the
ICU of a 206-bed hospital offering patient care to 800,000 active duty,
family members, and retiree population of all four armed services
(Table 1). Three additional VRE cultured from patients at the same facil-
ity but from an earlier time period were also included in the analysis
(Table 1). Identiﬁcation and antibiotic susceptibilities were performed
at a CAP-accredited clinical microbiology laboratory on a Vitek 2 auto-
mated susceptibility platform (Biomeriuex) using the Gram Positive
(GP) identiﬁcation panel and the GP AST71 panels, respectively.2.2. Outbreak investigation pipeline and Whole genome sequencing
Isolates were shipped overnight on TSA slants, and upon arrival
were cultured overnight at 37 °C on blood agar plates (BAP). DNA was
extracted using the Ultra-Clean Microbial DNA Isolation kit (MoBio
Inc. Carlsbad, CA, USA) and libraries were constructed using the KAPA
Hyperplus Library preparation kit (KAPA Biosciences, Wilmington,
MA, USA). Libraries were quantiﬁed using the KAPA Library Quantiﬁca-
tion Kit – Illumina/Bio-Rad iCycler (KAPA Biosciences) on a CFX96 real-
time cycler (Biorad, Hercules, CA, USA). Libraries were normalized to 2
nM, pooled, denatured, and diluted to 20 pM. The pooled samples
were further diluted to a ﬁnal concentration of 13 pM. Sampleswere se-
quenced using MiSeq Reagent Kit v3 (150 cycle; 2 × 75 bp) (Illumina,
San Diego, CA, USA).
In addition, after the outbreak investigation was completed new
libraries from fresh overnight cultures were prepared and sequenced
using the MiSeq Reagent Kit v2 (300 cycle; 2 × 150 bp) kits. These
kits take an additional 3 h to complete a sequencing run, but yield
longer reads.Table 1
Characteristics of VRE isolates used in this study.
MIC’s (
Barcode1 Date2 Source3 Location4 MLST5 CIP
33033 1 Blood ICU 78 ≥8 R
33034 12 Blood ICU 78 ≥8 R
33032 28 Pleural ﬂuid ICU 78 ≥8 R
14241 11/2012 Peritoneal ﬂuid ICU 78 ≥8 R
14246 01/2013 Blood ICU 192 ≥8 R
14513 01/2013 Catheter Ward 584 ≥8 R
Abbreviations used:MLST, Multi-locus sequence type; MIC, Minimum inhibitory concentration
TET, tetracycline; TGC, Tigecycline; VAN, vancomycin; SYN, Synergy.
1 Strain number, de-identiﬁed designation used to track isolates throughout the MRSN. Out
2 Outbreak strains: Expressed in days after the ﬁrst isolate was recovered from Patient 1; All
isolates were cultured.
3 Clinical site where the isolate was recovered.
4 Hospital location of the patient when isolate was recovered.
5 Based on in silico analysis of the whole genome sequence.
6 Antibiotic susceptibilities were determined using the Vitek 2 automated susceptibility plat2.3. Analysis of WGS data
Sequencing reads were quality and adapter trimmed and then de
novo assembled using Newbler (V2.7). The draft assembly of a single
outbreak strainwas used as the reference for readmapping and SNP de-
tection of the remaining strains. Reads from the reference strain were
also mapped, and SNP detection performed to detect any false SNPs
that could arise from errors in the draft assembly. Finally, the data was
reanalyzed using each strain as the reference to ensure SNPs were
valid. A combination of PanSeq (Laing et al., 2010) and Gegenees
(Agren et al., 2012) was also used to ensure sequence accuracy and to
detect any large scale rearrangements and/or deletions.
Sequencing at 2 × 75 bp resulted in 100% coverage of contigs greater
than 200 bp in lengthwith aminimum coverage of 36× (Average 78.6×,
Standard deviation 12.7). Sequencing at 2 × 150 bp resulted in 100%
coverage of contigs greater than 200 bp, with a minimum coverage of
42×. (Average 88×, Standard deviation 13.9). Both kits gave average
read coverage that exceeded the threshold for obtaining the maximum
N50 (Junemann et al., 2013).
Comparative genomic analyses were performed using Geneious
(Biomatters, Auckland, New Zealand) (Kearse et al., 2012). Antimicrobi-
al resistance genes were annotated using ResFinder 2.0 (Zankari et al.,
2012). Bowtie V2.2.4 (http://bowtie-bio.sourceforge.net/bowtie2/, last
accessed March 2016) was used for read mapping. Samtools/BCFtools
V1.2.1 (http://www.htslib.org/download/, last accessed March 2016),
and bedtools V2.23.0 (http://bedtools.readthedocs.org/en/stable/, last
accessed March 2016) were used for SNP calling and detection of
regions without read coverage
2.4. Nucleotide sequences
The Whole Genome Shotgun (WGS) sequence of MRSN 33033 has
been deposited at DDBJ/EMBL/Genbank WGS database with accession
number LPWB00000000. The SRA ﬁles for MRSN 33032, 33033, and
33034 have been deposited to the NCBI Bioprojects database (http://
www.ncbi.nlm.nih.gov/bioproject/306525) with accession numbers
SRR3306347, SRR3306348, and SRR3306349, respectively.
3. Results
3.1. Description of outbreak
A timeline of the outbreak, spanning 65 days, can be found in Fig. 1.
Patient 1was a 71 year-old (y.o.)malewithmultiplemedical comorbid-
ities, including gastrointestinal bleeding and ischemic colitis. Aμg/ml) and susceptibility call of6
ERY GEN LZD PEN TET TGC VAN
≥8 R SYN-S 2 S ≥64 R ≥16 R ≤0.12 S ≥32 R
≥8 R SYN-S 2 S ≥64 R ≥16 R ≤0.12 S ≥32 R
≥8 R SYN-S 2 S ≥64 R ≥16 R ≤0.12 S ≥32 R
≥8 R SYN-S 2 S ≥64 R ≥16 R ≤0.12 S ≥32 R
≥8 R SYN-S 2 S ≥64 R ≥16 R ≤0.12 S ≥32 R
≥8 R SYN-S 2 S ≥64 R ≤1 S ≤0.12 S ≥32 R
; CIP, Ciproﬂoxacin; ERY, Erythromycin, GEN, Gentamicin; LZD, Linezolid; PEN, Penicillin;
break strains are highlighted in bold font.
outbreak strains were cultured in 2015. Non-outbreak strains: The month and year when
formwith Gram Positive (GP) AST71 panels. Susceptibility call is based on CLSI guidelines.
Fig. 1. Timeline of suspected VRE outbreak among three patients. The outbreak occurred
over 65 days. Patient #1 is denoted with green text, patient #2 with red text, and patient
#3 with blue text.
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E. coli, Klebsiella oxytoca and VRE. A blood culture was positive for VRE
on Day 36, and on Day 37 the patient died due to septic shock with
multi-organ dysfunction. (See Fig. 2.)
Patient #2was a 69 y.o. femalewith toe gangrene. A transmetatarsal
amputation culture grew Corynebacterium species, Pantoea species,
E. faecalis, E. casseliﬂavus, Peptostreptococcus sp., and an unidentiﬁed
non-spore forming Gram-positive rod. The patient underwent further
amputation and developed transaminitis, coagulopathy, leukocytosis,
and a persistently elevated serum lactate. An exploratory laparotomyFig. 2. Dendrogram generated from the core genome sequence of VRE outbreak (Red)
and non-outbreak (blue) isolates. Genbank reference strains (black) have been added
for comparison. An alignment of concatenated SNPs was used for tree building with
RAxML V7.2.8 (sco.h-its.org/exelixis/web/software/raxml/, last accessed March 2016).
The scale represents nucleotide substitutions per site, expressed as a decimal (the number
of SNPs divided by the overall length of the sequence).revealed duodenal perforation and blood cultures grewVRE. The patient
died two days later from septic shock with multi-organ failure due to a
perforated duodenal ulcer.
Patient 3 was a 57 y.o. male with a history of chronic heart failure,
atrial ﬁbrillation/ﬂutter, and chronic kidney disease. He was admitted
for management of septic shockwithmulti-organ failure frommetasta-
tic MRSA of unknown etiology. VRE was cultured from the patient’s
pleural ﬂuid on Day 63, and the patient died the following day of cardio-
pulmonary arrest associated with MRSA bacteremia.
3.2. Evaluation of turnaround time (TAT)
A breakdown of the total TAT, including overnight culturing using
the 2 × 75 bp and 2 × 150 bp kits is presented in Table 2. Though the in-
strument run time was 3 h shorter with the 2 × 75 bp kits, this was off-
set by the 16-fold increase in the time required to assemble and quality
check (QC) the sequences when compared to the 2 × 150 bp kit (8 h
versus 0.5 h). This was attributable to the smaller read lengths generat-
ed by the2×75 bp kit,which complicated the assembly and subsequent
analysis (5.5 h versus 4.5 h; Table 2). Overall, the 2 × 150 bp kit was able
to provide a faster TAT than the 2 × 75 bp kit, despite the increased run
time. In addition to the longer assembly analysis time, the ﬁnal genome
assembly of MRSN 33033 consisted of 534 contigs and 154 scaffolds
when using the 2 × 75 bp kits, and 323 contigs and 147 scaffolds with
the 2 × 150 bp kits. This greater fragmentation of the ﬁnal genomes
with the 2×75bp kitwas also observed in all other sequenced genomes
(data not shown). As all of the reagents used for sequencing remain the
same, the only additional cost incurred is the price difference between
the 2 × 75 bp and 2 × 150 bp kits. Assuming 24 samples per run, this
is just $8.90 per genome at current prices (March 2016).
3.3. Outbreak analysis
MRSN 33033 was cultured from the blood of patient #1, and was
used as the reference sequence for generating a single nucleotide poly-
morphism (SNP) phylogenetic tree (Fig. 1). All isolates belonged to ST-
78, andWGS revealed that MRSN 33032 and MRSN 33034 were genet-
ically identical to MRSN 33033 with the exception of a single, unique,
non-synonymous mutation in both isolates. MRSN 33032 had a
Met92Ile substitution in a putative transcriptional regulator, while
MRSN 33034 had an Ile190Leu substitution in a putative multidrug
ABC transporter. Hence, nosocomial transmission between the patients
was the most probable cause of infection. Notably, rather than a trans-
mission from patient #1 to #2 to #3, as might be suspected from the
timeline, the distinct SNPs in the patient #2 and #3 isolates instead sug-
gested transmission from patient #1 (MRSN 33033) to patient #2 and
#3 in two separate events. As no patient was housed in the same
room concurrently, it was suspected that transmission was due to envi-
ronmental contamination. However, subsequent swabbing of the ICU
and attendant equipment failed to isolate VRE from any source. Thor-
ough cleaning of the implicated ICU room and sterilization of all equip-
ment used was performed and as of this writing (4months), no further
outbreaks of VRE have occurred.Table 2
Sequencing run metrics.
Time (h)
Procedure 150 bp kit 300 bp kit
Culture 12 12
DNA isolation 0.5 0.5
Library preparation 7 7
Run time 21 24`
Assembly and QC 8 0.5
Analysis and Report generation 5.5 4.5
Total time 54 48.5
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gene content
Antibiotic susceptibility data indicated resistance to a broad range of
antibiotics (Table 1). As part of the MRSN analysis pipeline, the assem-
bled genome is automatically searched for known antibiotic resistance
genes using an updated database of resistance genes rooted in
ResFinder (Zankari et al., 2012). The outbreak strains carried genes
known to encode resistance to the aminoglycosides, macrolides, tetra-
cyclines and vancomycin (Table 3), in accordancewith in vitro suscepti-
bilities (Table 1). Though no genes encoding resistance toβ-lactams and
ﬂuoroquinolones were detected, in vitro susceptibility data indicated
that the isolates had high level resistance to these antibiotics. Both β-
lactam and ﬂuoroquinolone resistance in enterococci have been linked
to mutations in genes encoding the targets of these drugs, speciﬁcally
pbp5 with β-lactams (Rice et al., 2004) and gyrA and parC with
ﬂuoroquinolones (Werner et al., 2010). Analysis of our VRE showed
that the S83Y GyrA and S80R ParC mutations described by Werner
et al. (2010) and the 466+S, M485A, I499T, and E629V mutations in
Pbp5 described by Rice et al. were present (Rice et al., 2004). Finally,
the outbreak strain carries aac(6′)-aph(2″), which encodes a bi-
functional aminoglycoside (Rouch et al., 1987) that confers resistance
to gentamicin, kanamycin and tobramycin (Ramirez and Tolmasky,
2010). Antibiotic susceptibility proﬁles indicated that all isolates were
resistant to gentamicin, but remained sensitive to gentamicin combina-
tion therapy (Table 1).
3.5. Comparison with non-outbreak associated VRE
Three additional VRE with similar antibiotic susceptibility proﬁles
(Table 1) and isolated from the same facility during the preceding 2
years were included in the analysis. Two of the 3 had been cultured
from patients housed in the same ICU where the outbreak took place.
In silicoMulti-locus Sequence type (MLST) revealed that all isolates be-
long to ST’s within E. faecium Clonal Complex 17 (CC-17), a hospital-
adapted clade with a global distribution (Willems et al., 2005). One iso-
late (MRSN 14241) was assigned to ST-78, the same ST as the outbreak
strains, but grouped closer to MRSN 14246, which belongs to ST-192, a
single-locus variant of ST-78 (Fig. 1). SNP-based analysis of the core ge-
nome revealed that a large 249 kb recombination event occurred in
both isolates, and was responsible for the majority of the SNP differ-
ences (556 SNPs) between these and the outbreak strains. This accumu-
lation of SNPs in a limited genetic region can be considered “pseudo-
SNPs” for investigating relatedness, as they do not reﬂect gradual accu-
mulation of SNPs by randommutation and can skew subsequent evolu-
tionary analysis. A second recombination event occurred in MRSN
14246, which added several hundred additional pseudo-SNPs and
hence a longer branch length on the phylogenetic tree (Fig. 1). When
these pseudo-SNPs were removed from the analysis, MRSN 14241 and
MRSN 14246 differed from MRSN 33033 by just 11 and 15 SNP’sTable 3
Antibiotic resistance genes carried by VRE outbreak strains.
Gene1 Target2 Accession3
aac(6′)-aph(2″) Aminoglycosides – gentamicin,
kanamycin and tobramycin
M13771
ant(6)-Ia Aminoglycosides – streptomycin AF330699






1 Based on closest match to NCBI database. All strains carry vanH, S, X, Y, and Z. in ad-
dition to vanA.
2 Predicted antibiotic resistance phenotype.
3 Corresponding NCBI accession number of the gene sequence.respectively. In contrast, MRSN 14513 had hundreds of SNP differences
randomly distributed across the core genome. The similarity in antibiot-
ic resistance proﬁles among isolates could be explained by the antibiotic
resistance gene content; the three non-outbreak strains had an almost
identical resistance gene content as the outbreak strains but MRSN
14240 and MRSN 14246 lacked the bi-functional aminoglycoside-
modifying enzyme AAC(6’)-APH(2”). In contrast, MRSN 14513 carried
aac(6′)-aph(2″) but it lacked tet(M) and tet(U) which correlated with
the sensitivity of this strain to tetracycline in vitro (Table 1).
4. Discussion
A suspected outbreak of VRE in the ICU of a large healthcare facility
provided the opportunity to determine a realistic TAT for generating
clinically relevant data in real-time usingWGS. Including overnight cul-
ture, a comprehensive report based on core genome phylogeny was
readily achievable in just over 48 h, providing a level of resolution that
cannot be provided by current typing methods such as PFGE and
MLST. The value of WGS went beyond simply determining relatedness,
with SNP-based analysis generating additional epidemiological data
that gave greater insights into the potential route of transmission as
well as providing valuable data on antibiotic susceptibilities.
The 48-hour TAT reported herein included every aspect of the pro-
cess, from overnight culture to report generation (Table 2). This was
achieved by utilizing themost recent advances in DNAextraction and li-
brary construction procedures, which generated pooled libraries ready
for sequencing in less than 8 h. The two most time-consuming aspects
of the procedure were overnight culturing and instrument run time,
though genome assembly and sequence QC times were excessively
high with the shorter read kits (Table 2). These times could be short-
ened further; For example, fast growing organisms could be cultured
for just 4–6 h, which would provide sufﬁcient material for DNA extrac-
tion and library construction. Alternatively, cultured bacteria could be
submitted via overnight courier, which would allow DNA extraction to
be performed immediately upon arrival. Furthermore, as DNA sequenc-
ing technologies continue to advance, the time to perform a sequencing
run is expected to fall signiﬁcantly.
These advances are remarkable when one considers that just eight
years ago a genomic analysis of Francisella tularensisusing pyrosequenc-
ing took over 6 weeks to complete, with DNA extraction alone taking 2
days (La Scola et al., 2008). In the ensuing years, TAT has steadily de-
creased,with Eyre et al. performingWGS and analysis on Staphylococcus
aureus and Clostridium difﬁcile in just 5 days (Eyre et al., 2012). More re-
cently, a TAT of just 48 h from culture to sequencing was demonstrated
during an outbreak of MRSA, but as sample preparation and DNA se-
quencing were performed off-site (Illumina), it is unclear if this was
achieved in real-time (Harris et al., 2013; Koser et al., 2012b).
Unlike other typing methods, NGS can be used to identify potential
antibiotic resistance genes (Diene and Rolain, 2013; Dunne et al.,
2012), as well as point mutations responsible for increased resistance
(Chin et al., 2013). As this technology evolves, the implementation of
NGS to determine the antibiotic resistance phenotype in near-real
time in a culture-independent manner is rapidly approaching (Diene
and Rolain, 2013; Dunne et al., 2012). Recent studies have shown the
utility of this approach (Gordon et al., 2014; Serizawa et al., 2010;
Stoesser et al., 2013), and have highlighted the barriers still remaining
to effectively translate this technology to the clinical laboratory (Koser
et al., 2014). In this study, an automated pipeline for detecting antibiotic
resistance genes based on the Resﬁnder database (Zankari et al., 2012),
identiﬁed eight genes encoding resistance to multiple antibiotic classes
(Table 3). These correlatedwith in vitro susceptibility data, butwere un-
able to account for the high-level resistance to penicillin and the
ﬂuoroquinolones (Table 1). Further analysis revealed point mutations
in the targets of these drugs that have previously been shown to confer
high-level resistance to these antibiotics (Rice et al., 2004;Werner et al.,
2010). This highlights one of the remaining challenges for effectively
281P. McGann et al. / Diagnostic Microbiology and Infectious Disease 85 (2016) 277–282implementing culture-independent susceptibility testing, namely the
creation and curation of databases describing point mutations that in-
crease antibiotic resistance (Gordon et al., 2014; Stoesser et al., 2013).
Recent studies have shown high concordance between genotype and
phenotype, with very major error and major error rates comparable to
that of culture-based techniques (Gordon et al., 2014; Koser et al.,
2012b; Stoesser et al., 2013), but validation on larger datasets is essen-
tial (Stoesser et al., 2013).
A unique aspect of whole genome sequencing is the ability to infer
transmission dynamics. In this study, initial epidemiological evidence,
based on the timeframe of the outbreak, suggested a linear transmission
from patient #1 to patient #2, and then from patient #2 to patient #3.
However, this paradigm was challenged by the SNP-based analysis;
MRSN 33032 and 33034 from patient #2 and patient #3 differed from
that of patient #1 (MRSN 33033) by just a single SNP, but this SNP
was different in both isolates. To support the initial assessment of trans-
mission, this would have required the SNP from MRSN 33032 to have
reverted to the original nucleotide inMRSN 33034,which then acquired
a new, unrelated SNP, a highly improbable event (1 in 9× 10−6). Amore
feasible explanation is that both patient #2 and #3 acquired the isolate
from patient #1, but in two separate events. This suggests that MRSN
33033 had contaminated the environment of the ICU room, which
then infected both patient #2 and #3. Extensive swabbing of the room
revealed no traces of VRE in the environment, but the extensive termi-
nal cleaning implemented after the death of patient #3 could have elim-
inated the reservoir prior to swabbing. This is supported by the fact that
no further VRE outbreaks occurred following IC intervention.
SNP-based analysis of the core genome has been utilized to infer
transmission and investigate the evolution of a number of pathogens
(Eyre et al., 2012; Harris et al., 2010, 2012, 2013; Harrison et al., 2013;
He et al., 2013; Koser et al., 2012b; Lopez-Camacho et al., 2014; Rasko
et al., 2011; Snitkin et al., 2012; Underwood et al., 2013). This has result-
ed in the adoption of SNP thresholds to determine the relatedness of iso-
lates [for a recent review see (Didelot et al., 2012)], though potential
hypermutator strains can skew the analysis, as reported for MRSA and
Acinetobacter baumannii (Komp Lindgren et al., 2015; Koser et al.,
2012b). In this study, 3 additional VRE from the same medical facility,
but collected years earlier were also sequenced (Table 1). Two isolates
were closely related to the outbreak strain but recombination events
had introduced hundreds of pseudo-SNPs. When these pseudo-SNPs
were removed, the two isolates differed from the outbreak strains by
just 11 and 15 SNP’s, respectively. Though no SNP threshold has been
established for VRE, these numbers are consistent with the mutation
rate in other species (Didelot et al., 2012). This close relationship with
the outbreak strains could be due to a single clone circulating within
the hospital, but the lack of consistent outbreaks over the last three
years does not support this hypothesis. As the isolates belong to the
hospital-adapted and globally distributed clonal complex 17 (Willems
et al., 2005), another possibility is that this clone is endemic within
the community and may reﬂect the success of this clone through con-
vergent evolution (Woodford et al., 2011). Continued surveillance of
VRE from this location is currently ongoing, with the aim of continually
reﬁning and updating the epidemiology of isolates within the facility.5. Conclusions
Weprovide the ﬁrst assessment of the utility ofWGS to provide data
in a clinically relevant timescale. The wealth of data provided by WGS
exceeds any other typing method currently available, including optical
mapping (Grad et al., 2012), particularly when trying to elucidate the
mechanism of transmission. In this report, culturing, sequencing, analy-
sis, and report generation were achieved in just 48 h, demonstrating
that an actionable TAT is not conﬁned to large sequencing centers
(Harris et al., 2013; Koser et al., 2012b) but can be accomplished by
small-scale laboratories.Acknowledgements
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